Proteomic Subtyping of Alzheimer’s Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic Biomarkers. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.